These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18283451)

  • 1. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.
    Boot E; Booij J; Hasler G; Zinkstok JR; de Haan L; Linszen DH; van Amelsvoort TA
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1350-6. PubMed ID: 18283451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.
    Braak B; Booij J; Klooker TK; van den Wijngaard RM; Boeckxstaens GE
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):642-50. PubMed ID: 22160229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging D2 receptor occupancy by endogenous dopamine in humans.
    Laruelle M; D'Souza CD; Baldwin RM; Abi-Dargham A; Kanes SJ; Fingado CL; Seibyl JP; Zoghbi SS; Bowers MB; Jatlow P; Charney DS; Innis RB
    Neuropsychopharmacology; 1997 Sep; 17(3):162-74. PubMed ID: 9272483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis.
    Bloemen OJ; de Koning MB; Gleich T; Meijer J; de Haan L; Linszen DH; Booij J; van Amelsvoort TA
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):126-32. PubMed ID: 22591910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective experiences during dopamine depletion.
    de Haan L; Booij J; Lavalye J; van Amelsvoort T; Linszen D
    Am J Psychiatry; 2005 Sep; 162(9):1755. PubMed ID: 16135643
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging.
    Voruganti L; Slomka P; Zabel P; Costa G; So A; Mattar A; Awad AG
    Neuropsychopharmacology; 2001 Nov; 25(5):642-50. PubMed ID: 11682247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S; Schlösser R; Hiemke C; Nickel O; Bockisch A; Hahn K
    Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
    Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M
    Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study.
    Boot E; Booij J; Zinkstok JR; de Haan L; Linszen DH; Baas F; van Amelsvoort TA
    J Psychopharmacol; 2010 Oct; 24(10):1525-31. PubMed ID: 19406852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
    Verstappen CC; Bloem BR; Haaxma CA; Oyen WJ; Horstink MW
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):502-7. PubMed ID: 17053905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
    Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
    J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.
    Meyer PT; Sattler B; Winz OH; Fundke R; Oehlwein C; Kendziorra K; Hesse S; Schaefer WM; Sabri O
    Neuroimage; 2008 Aug; 42(2):548-58. PubMed ID: 18595739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study.
    Voruganti LN; Awad AG
    Schizophr Res; 2006 Dec; 88(1-3):179-86. PubMed ID: 16949796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
    Catafau AM; Bullich S; Danús M; Penengo MM; Cot A; Abanades S; Farré M; Pavía J; Ros D
    Synapse; 2008 Jan; 62(1):62-9. PubMed ID: 17960766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.